This page shows the latest CNS news and features for those working in and with pharma, biotech and healthcare.
Swiss pharma giant Roche has partnered with Cambridge, Massachusetts-based Dyno Therapeutics for the development of gene therapies for central nervous system (CNS) and liver diseases. ... The companies will utilise Dyno’s CapsidMap platform to develop
Stop that! Back to the strategy workshop. The clients, on a verge of a huge investment in CNS, wanted to anticipate the market but, still in a reductionist prison, was focused
In addition, Tagrisso treatment also reduced the risk of CNS recurrence or death by 82%, although median CNS DFS was not reached yet in either arm of the study. ... According to AZ, CNS recurrence – in which the cancer spreads to the brain – is
This new collaboration with Tetra reinforces our steadfast commitment to advancing cutting-edge science in central nervous system (CNS) disorders including Alzheimer’s disease,” he added.
According to Nektar, NKTR-181 provides the same levels of pain relief as standard opioid products, but with reduced central nervous system (CNS) side-effects, namely euphoria.
According to Matteis, the Caplyta approval indicates that regulators will “often look at a mixed efficacy package in CNS through a 'glass half full lens'," due to the increased need for
More from news
Approximately 5 fully matching, plus 181 partially matching documents found.
that focused the company’s R&D strategy on cutting-edge, innovative approaches in GI, oncology and the central nervous system (CNS).
CNS disease drug development is traditionally viewed as higher risk and more expensive,” added Dr Roach.” I do not have privileged internal information about Pfizer’s neurological programmes, but many big ... Pfizer is probably in that category, so
We typically see more amendments in oncology and CNS. We also see a higher incidence and average number of amendments in later stage phase 2 and 3 studies.
These reporting rules require sponsors to upload information such as endpoints and eligibility criteria to www.chinadrugtrials.org.cn.
By Dr Peter Schueler, Senior Vice President, Drug Development Services and Haichen Yang, Vice President, Global Therapeutic Lead, both at CNS, ICON plc.
More from intelligence
Approximately 0 fully matching, plus 44 partially matching documents found.
During her time at J&J, Torres held several executive leadership roles including president of McNeil Consumer Healthcare and president of Janssen Pharmaceuticals, CNS.
He is a veteran biotech leader, with over 23 years of experience in rare diseases and CNS.
development. “We have a wonderful opportunity to develop life-changing medicines for patients with CNS diseases.
At Acadia, which focuses on the development and commercialisation of medicines for central nervous system (CNS) disorders, McDevitt will report to the company’s president and chief executive officer Steve Davis. ... This expertise, combined with his
Menezes joins the group from Depomed Pharmaceuticals, where he served as vice president of sales and sales operations, pain and CNS.
More from appointments
Approximately 0 fully matching, plus 27 partially matching documents found.
in central nervous system (CNS) and oncology trials. ... CNS trial dropout rates grew to 25.9% from 19.2. Oncology trial rates grew to 19.3% from 18.2%.
Lilianna Husseini, Director Communications, Oncology, Pfizer Global. Heidi LaPensée, Brand Lead, CNS, Sanofi UK.
Unlike the other organs in our body, the central nervous system (CNS) is surrounded by the Blood Brain Barrier (BBB). ... To say the BBB presents a formidable challenge in CNS drug development is an understatement.
Multiple Sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system (CNS), leading to progressive and permanent disability. ... In the central nervous system (CNS, which includes the brain, optic nerves and spinal cord),
Multiple Sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system (CNS), leading to progressive and permanent disability. ... In the central nervous system (CNS, which includes the brain, optic nerves and spinal cord),
More from PMHub
Approximately 0 fully matching, plus 11 partially matching documents found.
Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...